Save the date

Truveta Symposium 2025

April 28 - 30 | Seattle, WA

Healthcare, public health, and life sciences Saving Lives with Data together

Interested in attending Symposium? Reach out

Truveta Symposium uniquely brings together leaders from health systems, life sciences, and the government to collaborate on health research with real-world data, embracing generative AI to transform healthcare, and improving patient care and outcomes for all.

See the agenda

Sessions and presentations include:

^Truveta’s vision for trusted real-time healthcare insights
^Using real-world data to augment journals and replace slow and expensive registries and clinical trials
^Breakthroughs, challenges, and the future of metabolic and cardiovascular health
^Revolutionizing infectious disease surveillance with real-time, real-world data
^Harnessing real-world data to train AI models for accelerating therapy development and improving patient outcomes
^Integrating wearable device data with medical outcomes to revolutionize diabetes management
^Pioneering use of real-world data to drive innovation in vascular health and medical devices
^Delivering high-value patient care through strategic healthcare-life science partnerships
^Truveta Genome Project: Harnessing the power of genomic medicine and EHR data

Agenda

At-a-glance

Monday, April 28
Welcome reception beginning at 5pm. Presentation at 7 pm on USA Healthcare Facts with Steve Ballmer, founder of USA Facts, former Microsoft CEO, and owner, LA Clippers.

Tuesday, April 29
Daylong featured research and panel presentations from 8 am-5 pm, followed by dinner on the Seattle waterfront.

Wednesday, April 30
Keynote featuring Jay Nanduri, Truveta CTO at 8:30 am, followed by healthcare and researcher custom tracks until 1pm, including topics on data, AI and biospecimens and technical research enablement trainings.

Expand to see full agenda

Monday, April 28
USA Healthcare Facts	Steve Ballmer, Founder, USA Facts, former Microsoft CEO, and owner, LA Clippers

Tuesday, April 29
Saving Lives with Data – from discovery to care	Terry Myerson, CEO and co-founder, Truveta
A bold new era in medical evidence: Using real-world data to augment journals and replace slow and expensive registries and clinical trials	Ken Stein, MD, FACC, FHRS, SVP and Global Chief Medical Officer, Boston Scientific Michael Mack, MD, Associate Academic Officer, Baylor Scott & White Health; Chairman of the Board, Baylor Scott & White Research Institute Heather Rubino, PhD, MS, Head, Safety Surveillance Research, Pfizer Host: Ryan Ahern, Chief Medical Officer and co-founder, Truveta
Uncovering new insights through a broad research collaboration on GLP-1 medications and alcohol use	Tricia Rodriquez, PhD, MPH, Principal Applied Scientist, Truveta Joseph Levy, PhD, Assistand Professor, Johns Hopkins Bloomberg School of Public Health Ty Gluckman, MD, Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS) at Providence St. Joseph Health Jay Lusk, MD, MBA, Preventive Medicine Resident, Duke University Health System
Integrating wearable device data with medical outcomes to revolutionize diabetes management	Michelle Tressler, PhD, Vice President, Corporate Strategy, Dexcom
The emergence of general AI for biomedicine	Jonathan Carlson, PhD, Vice President and Managing Director, Microsoft Health Futures
Harnessing real-world data to train AI models for accelerating therapy development and improving patient outcomes	David Tingley, PhD, CEO and co-founder, Olio Labs
Revolutionizing oncology and infectious disease surveillance with real-time, real-world data	Scott Kelly, Senior Director, Epidemiology Strategy Lead, Pfizer
Uncovering trends in first-time measles vaccine guideline adherence	Brianna Cartwright, MS, Principal Research Analyst, Truveta
Delivering high-value patient care through strategic healthcare-life science partnership	Prof. Rifat Atun, MD, Professor of Global Health Systems, Harvard University and Director, Harvard Health Systems Innovation Lab Greg Gillum, RN, MSN, Director, Medical Affairs Impact and Data Enablement, Boehringer-Ingelheim Petros Okubagzi, MD, VP, Clinical and Translational Research, MedStar Health Research Institute
Insights from Truveta Data: Lyme disease and female reproductive health	Nasa Sinnott-Armstrong, PhD, Assistant Professor, Herbold Computational Biology Program Public Health Sciences Division, Fred Hutch Cancer Center
Real world survival assessment of CCM: An example of successful use of Truveta Data	Ishu V. Rao, MD, Senior Vice President of Medical Affairs, Impulse Dynamics
The next evolution of RWD for cancer research	Michael Simonov, MD, Vice President of Product, Truveta
Truveta Genome Project: Harnessing the power of genomic medicine and EHR data	Jeff Boyd, PhD, Chief Scientific Officer, Director, Center of Genomic Medicine, Northwell Health Cancer Institute Marcus Jones, Executive Director, Regeneron
Dinner on the Seattle waterfront

Wednesday, April 30

Truveta’s agentic architecture for data quality, biospecimen supply chain, and real-time insights

Jay Nanduri, Chief Technical Oficer and co-founder, Truveta

Healthcare track:

Our partnership: health system members + Truveta
Enabling new use cases with Truveta Data and Truveta Studio
Genomics program and partnerships

Researcher track:

Hands-on training: Notebooks, large population refinement, data quality filtering, and more
New research user groups and small group discussions
Q&A with Truveta product leaders and roadmap

Presenters

Rifat Atun, MD

Professor of Global Health Systems, Harvard University and Director, Harvard Health System Innovation Lab

Harvard University

Jeff Boyd, PhD

Chief Scientific Officer, Dir. Center for Genomic Medicine

Northwell Health Cancer Institute

Brianna Cartwright, MS

Principal Research Analyst

Truveta

Jonathan Carlson, PhD

Vice President & Managing Director

Microsoft Health Futures

Greg Gillum, RN, MSN

Director, Medical Affairs Impact and Data Enablement

Boehringer-Ingelheim

Ty Gluckman, MD

Medical Director

Center for Cardiovascular Analytics, Research, and Data Science (CARDS) at Providence St. Joseph Health

Rod Hochman, MD

CEO Emeritus

Providence

Marcus Jones

Executive Director

Regeneron

Scott Kelly

Senior Director, Epidemiology Strategy Lead

Pfizer

Joseph Levy, PhD

Assistant Professor

Johns Hopkins Bloomberg School of Public Health

Jay Lusk, MD, MBA

Duke University Health System

Michael Mack, MD

Associate Academic Officer, Baylor Scott & White Health; Chairman of the Board, Baylor Scott & White Research Institute

Baylor Scott & White Health

Terry Myerson

CEO and co-founder

Truveta

Petros Okubagzi, MS

VP, Clinical and Translational Research

MedStar Health Research Institute

Ishu V. Rao, MD

Senior Vice President of Medical Affairs

Impulse Dynamics

Tricia Rodriquez, PhD, MPH

Principal Applied Scientist

Truveta

Heather Rubino, PhD, MS

Head, Safety Surveillance Research

Pfizer

Michael Simonov, MD

VP of Product

Truveta

Nasa Sinnott-Armstrong, PhD

Assistant Professor, Herbold Computational Biology Program Public Health Sciences Division

Fred Hutch Cancer Center

Ken Stein

SVP and Global Chief Medical Officer

Boston Scientific

David Tingley, PhD

Co-founder and CEO

Olio Labs

Michelle Tressler, PhD

Vice President, Strategic Planning

Dexcom

“Trusted real-world data has the potential to advance care, address health inequities, and accelerate science. It is an honor to bring together innovative industry leaders and renowned researchers across health systems, public health, and life science at Truveta Symposium this week. The collaborations established here have the potential to rapidly accelerate our shared mission of Saving Lives with Data.”

Terry Myerson

Chief Executive Officer & co-founder, Truveta

“We have an opportunity to democratize care by connecting leaders across healthcare to learn, collaborate, and dream together. Truveta Symposium enables us to join forces and accelerate progress in critical areas like cardiovascular, oncology, and rare diseases to advance care for everyone.”

Rod Hochman, MD

President & CEO, Providence; Truveta board chair

“From my earliest discussions with Truveta, I saw the unique opportunity for leaders across healthcare to come together with a shared mission. Truveta Symposium creates this opportunity for us to come together, explore fascinating research, and discuss the opportunities and challenges facing us today with much hope for the future.”